pre-seed
Stage
1
Investors
About
Gearbox Biosciences develops an antibiotic-free platform technology for producing plasmid DNA and recombinant proteins in engineered E. coli, enabling high-yield, antibiotic- and inducer-free production suitable for gene therapy and vaccine applications.
Explore Gearbox Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.